Diffuse large B-cell lymphoma: open trials in United States

• NCT05487170

  A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)

  Trial Treatment · Phase 1/2 · Ranok Therapeutics (Hangzhou) Co., Ltd.

  Emory University/Winship Cancer Institute, Atlanta · Norton Cancer Institute, Louisville · Weill Cornell - NY Presbyterian Hospital, New York

  Registry updated 2025-03-04

• NCT05281809

  Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

  Trial Treatment · Phase 2 · John Lister

  AHN Cancer Institute - West Penn Hospital, Pittsburgh

  Registry updated 2025-01-13

• NCT06238648

  Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

  Trial Treatment · Phase 2 · Academic and Community Cancer Research United

  UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Hackensack University Medical Center, Hackensack · Memorial Sloan-Kettering Cancer Center, New York · Mayo Clinic in Rochester, Rochester · Huntsman Cancer Institute/University of Utah, Salt Lake City · Siteman Cancer Center at Washington University, St Louis

  Registry updated 2024-09-26

• NCT05255354

  Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy

  Research · Adaptive Biotechnologies

  Stanford Cancer Center, Palo Alto

  Registry updated 2024-08-22

• NCT04920617

  DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  Trial Treatment · Phase 2 · ImmunoVaccine Technologies, Inc. (IMV Inc.)

  Blood and Marrow Transplant Group of Georgia, Atlanta · Boca Raton Regional Hospital, Boca Raton · Gabrail Cancer Center Research, Canton · Compassionate Cancer Care Medical Group, Fountain Valley · Brody School of Medicine at East Carolina University, Greenville · BRCR Medical Center Inc., Hollywood · Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis · Tulane Cancer Center Office of Clinical Research, New Orleans · Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha · Allegheny Health Network (AHN) West Penn Hospital, Pittsburgh · BRCR Medical Center Inc, Plantation · CHRISTUS St. Vincent Regional Cancer Center, Santa Fe · Comprehensive Hematology and Oncology, St. Petersburg · University of Toledo Medical Center, Toledo · Toledo Clinic Cancer Center, Toledo · Prairie Lakes Health Care System, Watertown · Reading Hospital - McGlinn Cancer Institute, West Reading

  Registry updated 2023-04-07

• NCT04502394

  Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

  Trial Treatment · Phase 1/2 · Kartos Therapeutics, Inc.

  University of Cincinnati, Cincinnati · The Ohio State University Comprehensive Cancer Center, Columbus · UT Southwestern Medical Center, Dallas · Goshen Center for Cancer Care, Goshen

  Registry updated 2022-08-04

All Diffuse large B-cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error